Nuclear Medicine
CAPSUBAC
Name:
Capsubac-Sodium Iodide (131I)
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in:
– Graves’ disease, single or multiple diffuse toxic multinodular goiter or autonomous thyroid nodules.
– For the treatment of papillary and follicular carcinoma of the thyroid, including recurrent metastatic disease after surgery. Sodium iodide (131I) treatment is often associated with surgery and antithyroid drugs.
Nuclear Medicine
CAPSUBAC
Name:
Capsubac-Sodium Iodide (131I)
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in:
– Graves’ disease, single or multiple diffuse toxic multinodular goiter or autonomous thyroid nodules.
– For the treatment of papillary and follicular carcinoma of the thyroid, including recurrent metastatic disease after surgery. Sodium iodide (131I) treatment is often associated with surgery and antithyroid drugs.
RELATED PRODUCTS
-
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.

